Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.

Adeno-associated viral gene therapy has shown great promise in treating retinal disorders, with three promising clinical trials in progress. Numerous adeno-associated virus (AAV) serotypes can infect various cells of the retina when administered subretinally, but the retinal detachment accompanying this injection induces changes that negatively impact the microenvironment and survival of retinal neurons. Intravitreal administration could circumvent this problem, but only AAV2 can infect retinal cells from the vitreous, and transduction is limited to the inner retina. We therefore sought to investigate and reduce barriers to transduction from the vitreous. We fluorescently labeled several AAV serotype capsids and followed their retinal distribution after intravitreal injection. AAV2, 8, and 9 accumulate at the vitreoretinal junction. AAV1 and 5 show no accumulation, indicating a lack of appropriate receptors at the inner limiting membrane (ILM). Importantly, mild digestion of the ILM with a nonspecific protease enabled substantially enhanced transduction of multiple retinal cell types from the vitreous, with AAV5 mediating particularly remarkable expression in all retinal layers. This protease treatment has no effect on retinal function as shown by electroretinogram (ERG) and visual cortex cell population responses. These findings may help avoid limitations, risks, and damage associated with subretinal injections currently necessary for clinical gene therapy.

[1]  T. Aleman,et al.  Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Kuhn,et al.  Internal limiting membrane removal in the management of full-thickness macular holes. , 2000, American journal of ophthalmology.

[3]  Edward B. Miller,et al.  Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. , 2006, Journal of virology.

[4]  R. Samulski,et al.  Infectious Entry Pathway of Adeno-Associated Virus and Adeno-Associated Virus Vectors , 2000, Journal of Virology.

[5]  A. J. Roman,et al.  Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations. , 2009, Investigative ophthalmology & visual science.

[6]  J. Bennett,et al.  Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. , 2008, The Journal of clinical investigation.

[7]  L. Enquist,et al.  Intravitreal Injection of the Attenuated Pseudorabies Virus PRV Bartha Results in Infection of the Hamster Suprachiasmatic Nucleus Only by Retrograde Transsynaptic Transport via Autonomic Circuits , 2002, The Journal of Neuroscience.

[8]  W. Halfter.  Disruption of the retinal basal lamina during early embryonic development leads to a retraction of vitreal end feet, an increased number of ganglion cells, and aberrant axonal outgrowth , 1998, The Journal of comparative neurology.

[9]  T. Flotte,et al.  Clinical gene therapy using recombinant adeno-associated virus vectors , 2008, Gene Therapy.

[10]  W. Hauswirth,et al.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  G. Kobinger,et al.  Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. , 2001, Human molecular genetics.

[12]  F. Chan,et al.  Expression pattern of Glycoconjugates in Rat Retina as Analysed by Lectin Histochemistry , 2004, The Histochemical Journal.

[13]  C. Mussolino,et al.  Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors , 2007, Journal of Virology.

[14]  J. Bennett,et al.  Novel AAV serotypes for improved ocular gene transfer , 2008, The journal of gene medicine.

[15]  D. Hyde,et al.  Mutations in laminin alpha 1 result in complex, lens-independent ocular phenotypes in zebrafish. , 2006, Developmental biology.

[16]  Y. Chérel,et al.  Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  E. Surace,et al.  Versatility of AAV vectors for retinal gene transfer , 2008, Vision Research.

[18]  L. Chai,et al.  Heparan Sulfate in the Inner Limiting Membrane of Embryonic Chicken Retina Binds Basic Fibroblast Growth Factor to Promote Axonal Outgrowth , 1999, Experimental Neurology.

[19]  R. Samulski,et al.  Adeno-associated virus serotypes: vector toolkit for human gene therapy. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  J. Grieger,et al.  Production and characterization of adeno-associated viral vectors , 2006, Nature Protocols.

[21]  S. Heegaard,et al.  Structure and composition of the inner limiting membrane of the retina , 1986, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  J. Morris,et al.  Distribution of heparan sulfate proteoglycans in embryonic chicken neural retina and isolated inner limiting membrane. , 1994, Current eye research.

[23]  M. Gonçalves.  Adeno-associated virus: from defective virus to effective vector , 2005, Virology Journal.

[24]  Edward B. Miller,et al.  α2,3 and α2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6 , 2006, Journal of Virology.

[25]  Geoffrey P. Lewis,et al.  Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment , 2005, Progress in Retinal and Eye Research.

[26]  A. Eller,et al.  Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body , 2008, Eye.

[27]  Edwin M Stone,et al.  Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. , 2009, Investigative ophthalmology & visual science.

[28]  Michael Hallek,et al.  Recent developments in adeno‐associated virus vector technology , 2008, The journal of gene medicine.

[29]  D. Mccarty.  Self-complementary AAV vectors; advances and applications. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  M. Agbandje-McKenna,et al.  Proteolytic mapping of the adeno-associated virus capsid. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  A. R. Harvey,et al.  Intravitreal Injection of Adeno-associated Viral Vectors Results in the Transduction of Different Types of Retinal Neurons in Neonatal and Adult Rats: A Comparison with Lentiviral Vectors , 2002, Molecular and Cellular Neuroscience.

[32]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[33]  N. Muzyczka,et al.  Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses , 2008, Proceedings of the National Academy of Sciences.

[34]  L. Smillie,et al.  An improved fractionation system for pronase on CM-sephadex. , 1971, Canadian journal of biochemistry.

[35]  W. Hauswirth,et al.  Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. , 2008, Human gene therapy.

[36]  M. Kay,et al.  The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.

[37]  W. Halfter,et al.  Biomechanical properties of native basement membranes , 2007, The FEBS journal.

[38]  M. R. Delgado Alvira,et al.  Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues , 2004, Journal of Virology.

[39]  J. Chiorini,et al.  Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity , 2001, Journal of Virology.

[40]  J. Chamberlain,et al.  Recombinant adeno-associated virus transduction and integration. , 2008, Molecular Therapy.